Review of hemostatic agents used in dentistry

Dentistry Today

Volumn 24, Issue 3, 2005, Pages 62-65

  McBee, William L ^a,b   Koerner, Karl R ^a,b  

^a MedSpring Group Medical Advisory Board ^*

^b MedSpring Group Medical Advisory Board

Author keywords

[No Author keywords available]

Indexed keywords

HEMOSTATIC AGENT;

ARTICLE; BLEEDING; HUMAN; ORAL BLEEDING; ORAL SURGERY; TOOTH PAIN;

BLOOD LOSS, SURGICAL; DRY SOCKET; HEMOSTATICS; HUMANS; ORAL HEMORRHAGE; ORAL SURGICAL PROCEDURES;

EID: 16744369155     PISSN: 87502186     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. Ogle OE. Perioperative hemorrhage. In: Dym H, Ogle OE. Atlas of Minor Oral Surgery. Philadelphia, Pa: WB Saunders; 2000:62-63.
2. Platelets and primary hemostasis. In: Andreoli TE, Bennett JC, Carpenter CCJ, et al. Cecil Essentials of Medicine. 4th ed. Philadelphia, Pa: WB Saunders; 1997:403.
3. CollaPlug [package insert]. Plainsboro, NJ: Integra LifeSciences Corp; 2001.
4. Guralnick W, Berg L. GELFOAM in oral surgery. Oral Surg. 1948;1:629-632.
5. Jenkins HP, Janda R, Clarke J. Clinical and experimental observations on the use of gelatin sponge or foam. Surgery. 1946;20:124-132.
6. Jenkins HP, Janda R. Studies on the use of gelatin sponge or foam as a hemostatic agent in experimental liver resections and injuries to large veins. Ann Surg. 1946;124:952-961.
7. Correll JT, Prentice HR, Wise EC. Biologic investigations of a new absorbable sponge. Surg Gynecol Obstet. 1945;181:585-589.
8. Council on Pharmacy and Chemistry. Absorbable gelatin sponge: new and nonofficial remedies. JAMA. 1947;135:921.
9. Jenkins HP, Senz EH, Owen H, et al. Present status of gelatin sponge for control of hemorrhage. JAMA. 1946;132:614-619.
10. Treves N. Prophylaxis of post mammectomy lymphedema by the use of GELFOAM laminated rolls. Cancer. 1952;5:73-83.
11. Barnes AC. The use of gelatin foam sponges in obstetrics and gynecology. Am J Obstet Gynecol. 1963;86:105-107.
12. Rarig HR. Successful use of gelatin foam sponge in surgical restoration of fertility. Am J Obstet Gynecol. 1963;86:136.
13. Gelfoam [package insert]. Kalamazoo, Mich: Pharmacia; 1999.
14. ETHICON Bone Wax [package insert]. Somerville, NJ: Ethicon Inc; 1997.
15. Surgicel Fibrillar Hemostat [package insert]. Somerville, NJ: Ethicon Inc; 1998.
16. Dineen P. Antibacterial activity of oxidized regenerated cellulose. Surg Gynecol Obstet. 1976;142:481-486.
17. Dineen P. The effect of oxidized regenerated cellulose on experimental intravascular infection. Surgery. 1977;82:576-579.
18. Dineen P. The effect of oxidized regenerated cellulose on experimental infected splenotomies. J Surg Res. 1977;23:114-125.
19. Kuchta N, Dineen P. Effects of absorbable hemostats on intraabdominal sepsis. Infections in Surgery. 1983;2:441-445.
20. Ibrahim MF, Aps C, Young CP. A foreign body reaction to Surgicel mimicking an abscess following cardiac surgery [letter]. Eur J Cardiothorac Surg. 2002;22:489-490.
21. Krishnan LK, Mohanty M, Umashankar PR, et al. Comparative evaluation of absorbable hemostats: advantages of fibrin-based sheets. Biomaterials. 2004;25:5557-5563.
22. Kothbauer KF, Jallo GI, Siffert J, et al. Foreign body reaction to hemostatic materials mimicking recurrent brain tumor: report of three cases. J Neurosurg. 2001;95:503-506.
23. Zhang Qin-shang, Xu Qing-zhong. Application of S-99 soluble styptic gauze to wounds. Beijing Xuan Wu Hospital, Departments of Pathology and Stomatology. Beijing, China. December 31, 1982: personal communication.
24. Data on file. Nelson Laboratories, Inc; Salt Lake City, Utah; Telephone: (801) 963-2600.
25. Hematologic problems. In: Barker LR, Burton JR, Zieve PD eds. Principles of Ambulatory Medicine. 5th ed. Baltimore, Md: Williams & Wilkins; 1999:641.
26. Berge TI, Boe OE. Predictor evaluation of postoperative morbidity after surgical removal of mandibular third molars. Acta Odontol Scand. 1994;52:162-169.
27. Swanson AE. Prevention of dry socket: an overview. Oral Surg Oral Med Oral Pathol. 1990;70:131-136.
28. Krekmanov L. Alveolitis after operative removal of third molars in the mandible. Int J Oral Surg. 1981;10:173-179.
29. Osborn TP, Frederickson G Jr, Small IA, et al. A prospective study of complications related to mandibular third molar surgery. J Oral Maxillofac Surg. 1985;43:767-769.
30. Quinley JF, Royer RQ, Gores RJ. "Dry socket" after mandibular odontectomy and use of soluble tetracycline hydrochloride. Oral Surg Oral Med Oral Pathol. 1960;13:38-42.
31. Goldman DR, Kilgore DS, Panzer JD, et al. Prevention of dry socket by local application of lincomycin in Gelfoam. Oral Surg Oral Med Oral Pathol. 1973;35:472-474.
32. Julius LL, Hungerford RW, Nelson WJ, et al. Prevention of dry socket with local application of Terra-Cortril in gelfoam. J Oral Maxillofac Surg. 1982;40:285-286.
33. Rood JP, Murgatroyd J. Metronidazole in the prevention of 'dry socket'. Br J Oral Surg. 1979;17:62-70.
34. Krekmanov L, Nordenram A. Postoperative complications after surgical removal of mandibular third molars: effects of penicillin V and chlorhexidine. Int J Oral Maxillofac Surg. 1986;15:25-29.
35. Mitchell DA. A controlled clinical trial of prophylactic tinidazole for chemoprophylaxis in third molar surgery. Br Dent J. 1986;160:284-286.